跳至主要内容
临床试验/NCT02616432
NCT02616432进行中(未招募)不适用

Tomosynthesis Mammography Imaging Screening Trial Lead-in

Sunnybrook Health Sciences Centre8 个研究点 分布在 1 个国家目标入组 3,065 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
3,065
试验地点
8
主要终点
Diagnostic Accuracy of DBT vs FFDM - AUC under ROC comparison

研究概览

简要总结

A randomized screening trial to compare the diagnostic accuracy of screening for breast cancer with three-dimensional digital breast tomosynthesis (DBT) plus two-dimensional full-field digital mammography (FFDM) versus FFDM alone.

详细描述

The Tomosynthesis Mammography Imaging Screening Trial (TMIST) LEAD-IN is being conducted to ensure that all Eastern Cooperative Oncology Group / American College of Radiology Imaging Network (ECOG/ACRIN) TMIST components are properly functional and to provide an opportunity for fine tuning before launching the full TMIST. The accrual target for TMIST LEAD-IN is 6354 participants (one tenth of the projected enrollment target for TMIST) at three lead-in study sites: 1. Sunnybrook Health Sciences Centre in Toronto, 2. Vancouver (under the auspices of the Screening Mammography Programme of British Columbia) and 3. The Ottawa Hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Asymptomatic women age 40 and over
  • Scheduled for screening mammogram
  • Able to tolerate digital breast tomosynthesis and full-field digital mammographic imaging required by protocol
  • Willing and able to provide a written informed consent.

排除标准

  • Presenting for mammography with symptoms of breast disease
  • Have new breast complaints (e.g. lump, nipple discharge)
  • Have had a mammogram of both breasts within the last 11 months
  • Previous personal history of breast cancer
  • Has breast enhancements (e.g. implants or injections)
  • Pregnancy or intent to become pregnant.

结局指标

主要结局

Diagnostic Accuracy of DBT vs FFDM - AUC under ROC comparison

时间窗: 3 year follow-up

To compare the diagnostic accuracy using the area under the curve (AUC) score generated by receiver operator characteristic (ROC) analysis of digital breast tomosynthesis plus full-field digital mammography (DBT) versus full-field digital mammography (FFDM) alone for breast cancer screening. The examinations will be interpreted by local Breast Imaging radiologists. Cancer status will be pathologically confirmed. The women would undergo three consecutive screening rounds in the assigned arm followed by one year of standard of care imaging follow-up.

次要结局

  • Recall Rates(3 year)
  • Interval Cancers(3 year)
  • Prevalence of Breast Cancer Subtypes(3 year)
  • Reader Studies of variations of DBT vs FFDM - AUC under ROC comparison(4 year)
  • Biomarker Correlation(2 year)
  • Clinical Characteristics of Cancers(3 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Roberta Jong

Principal Investigator

Sunnybrook Health Sciences Centre

研究点 (8)

Loading locations...

相似试验

Tomosynthesis Mammographic Imaging Screening Trial | 临床试验